Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
NASDAQ:TNDM
RESEARCH TOOLSreports
Holding TNDM?
Track your performance easily
TNDM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$20.52 - $53.69
Previous Close$30.63
Volume446.55K
Average Volume (3M)1.35M
Market Cap
$2.01B
Enterprise Value$2.01B
Total Cash (Recent Filing)$473.31M
Total Debt (Recent Filing)$475.95M
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Feb 19, 2025EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.94
Shares Outstanding65,676,532
10 Day Avg. Volume2,026,835
30 Day Avg. Volume1,354,027
Standard Deviation0.18
R-Squared0.15
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)8.33
Price to Sales (P/S)2.14
Price to Cash Flow (P/CF)17.10
P/FCF Ratio21.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.36
Enterprise Value/Gross Profit5.48
Enterprise Value/Ebitda-26.49
Forecast
1Y Price Target
$52.93Price Target Upside72.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Tandem Diabetes Care News
Bulls Say, Bears Say
Bulls Say
Market ExpansionTNDM has captured approximately 25% share of the U.S. insulin pump market given success with its market-leading Control-IQ AID system.
Product AdoptionThe return to year-over-year new pump growth in the US, with more than half of the shipments to new users, shows strong market demand.
Revenue GrowthTNDM delivered the highest quarterly sales in its history, both in the US and internationally.
Bears Say
Guidance And Growth ExpectationsManagement's updated 4Q-24 U.S. guidance also suggests a slowing in 4Q y/y domestic growth to ~14-17%.
Market Share And CompetitionSurvey results suggest more limited MDI share recapture for Mobi than bulls seem to expect.
Profitability And Market ChallengesFurther upside requires higher Type 2 adoption, greater share gains, or accelerated profitability improvements, which are currently not assured.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TNDM FAQ
What was Tandem Diabetes Care’s price range in the past 12 months?
Tandem Diabetes Care lowest stock price was $20.52 and its highest was $53.69 in the past 12 months.
What is Tandem Diabetes Care’s market cap?
Currently, no data Available
When is Tandem Diabetes Care’s upcoming earnings report date?
Tandem Diabetes Care’s upcoming earnings report date is Feb 19, 2025 which is in 60 days.
How were Tandem Diabetes Care’s earnings last quarter?
Tandem Diabetes Care released its earnings results on Nov 06, 2024. The company reported -$0.35 earnings per share for the quarter, beating the consensus estimate of -$0.407 by $0.057.
Is Tandem Diabetes Care overvalued?
According to Wall Street analysts Tandem Diabetes Care’s price is currently Undervalued.
Does Tandem Diabetes Care pay dividends?
Tandem Diabetes Care does not currently pay dividends.
What is Tandem Diabetes Care’s EPS estimate?
Tandem Diabetes Care’s EPS estimate is -$0.21.
How many shares outstanding does Tandem Diabetes Care have?
Tandem Diabetes Care has 65,676,530 shares outstanding.
What happened to Tandem Diabetes Care’s price movement after its last earnings report?
Tandem Diabetes Care reported an EPS of -$0.35 in its last earnings report, beating expectations of -$0.407. Following the earnings report the stock price went down -2.687%.
Which hedge fund is a major shareholder of Tandem Diabetes Care?
Among the largest hedge funds holding Tandem Diabetes Care’s share is Gilder Gagnon Howe & Co LLC.. It holds Tandem Diabetes Care’s shares valued at 37M.
---
Tandem Diabetes Care Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$52.93 (72.80% Upside)
$52.93 (72.80% Upside)
Blogger Sentiment
Bullish
TNDM Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 331.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.6%
Last 30 Days ▲ 8.8%
Last 30 Days ▲ 8.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
54.54%
12-Months-Change
Fundamentals
Return on Equity
-45.96%
Trailing 12-Months
Asset Growth
1.90%
Trailing 12-Months
Company Description
Tandem Diabetes Care
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
---
TNDM Company Deck
---
TNDM Earnings Call
Q3 2024
0:00 / 0:00
---
TNDM Revenue Breakdown
74.21% U.S.
25.79% International
---
TNDM Stock 12 Month Forecast
Average Price Target
$52.93
▲(72.80% Upside)
Technical Analysis
Best Analysts Covering TNDM
1 Year
1 Year Success Rate
21/28 ratings generated profit
1 Year Average Return
+124.11%
reiterated a buy rating 5 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +124.11% per trade.
---